Psychiatry and Neurology, Neurology · Baltimore, MD
NPI
1659714574
Since 2013
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
201 N Broadway St
Baltimore, MD, 21287
Phone (501) 786-9272
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
403 services
Medicare patients, 2024
115
Average age 64
Drug cost, 2024
$814K
461 prescriptions
Company payments, 2025
$124
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Orwa Aboud was code 99215 (office e&m - established), 150 times for 67 patients. In total Orwa Aboud billed 403 services in 19 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 150 | 67 | $112.27 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 118 | 58 | $13.42 | $1,583 |
| 99232 Hospital E&M - Subsequent | Facility | 25 | 14 | $63.67 | $1,592 |
| 99205 Office E&M - New | Facility | 20 | 20 | $146.27 | $2,925 |
| 99442 Telephone Services | Facility | 17 | 12 | $53.19 | $904 |
| 99214 Office E&M - Established | Facility | 15 | 12 | $73.37 | $1,101 |
By year: 2022 $27K for 276 services; 2023 $22K for 208 services; 2024 $29K for 403 services.
Medicare prescription drug claims, 2024
In 2024, the drug Orwa Aboud prescribed most often to Medicare patients was Levetiracetam, with 49 prescriptions and refills. In total Orwa Aboud wrote 461 Medicare prescriptions that cost $814K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 49 | 76 | 14 | $2,447 |
| Dexamethasone Generic | 43 | 51 | 14 | $582 |
| Ondansetron Hcl Generic | 40 | 40 | 17 | $8,228 |
| Lacosamide Generic | 29 | 41 | Under 11 | $5,234 |
| Everolimus Generic | 26 | 26 | Under 11 | $147K |
| Gabapentin Generic | 21 | 31 | Under 11 | $396 |
| Duloxetine Hcl Generic | 17 | 19 | Under 11 | $298 |
| Koselugo Selumetinib Sulfate | 15 | 15 | Under 11 | $295K |
| Pregabalin Generic | 13 | 13 | Under 11 | $70.12 |
| Eliquis Apixaban | 13 | 15 | Under 11 | $9,235 |
| Belbuca Buprenorphine Hcl | 12 | 12 | Under 11 | $11K |
| Welireg Belzutifan | 12 | 12 | Under 11 | $224K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 12 | 12 | 11 | $23.8 |
Brand drugs: 76 claims; generic drugs: 385 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Orwa Aboud $124 ($124 in general payments such as food, travel and fees) from 1 company. The largest payer was Alexion Pharmaceuticals, Inc. with $124.
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. AZN | 1 | $124 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.